Shopping Cart 0
Cart Subtotal
USD 0

Faron Pharmaceuticals Oy (FARN) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Faron Pharmaceuticals Oy (Faron) is a clinical stage biopharmaceutical company that conducts clinical stage drug discovery and development. The company's pipeline products focus on cute organ traumas, vascular damage and cancer immunotherapy. It offers Traumakine, that helps to prevent vascular leakage and organ failures and is the only treatment for acute respiratory distress syndrome (ARDS). Faron's Clevegen is a pre-clinical anti-Clever-1 antibody that has the ability to switch immune suppression to immune activation in various conditions. The company's Clevegen can be used for oncology, infectious disease and vaccine development. It partners with academic institutions and pharmaceutical companies. Faron is headquartered in Turku, Finland.

Faron Pharmaceuticals Oy (FARN)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Faron Pharmaceuticals Oy, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Faron Pharmaceuticals Oy, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Faron Pharmaceuticals Oy, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Faron Pharmaceuticals Oy, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Faron Pharmaceuticals Oy, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Faron Pharmaceuticals Oy, Medical Equipment, Deal Details 10

Equity Offering 10

Faron Pharma Raises USD10 Million in Second Tranche of Private Placement of Shares 10

Faron Pharma Raises USD0.5 Million in Second Tranche of Rights Offering of Shares 12

Faron Pharma Raises USD13.3 Million in Private Placement of Shares 13

Faron Pharma Raises USD11.9 Million in Private Placement of Shares 14

Faron Pharma Raises USD1.3 Million in Rights Offering of Shares 15

Faron Pharma to Raise USD0.1 Million in Private Placement of Shares upon Exercise of Warrants 16

Faron Pharma Raises Funds in IPO 17

Faron Pharmaceuticals Oy-Key Competitors 18

Faron Pharmaceuticals Oy-Key Employees 19

Faron Pharmaceuticals Oy-Locations And Subsidiaries 20

Head Office 20

Recent Developments 21

Financial Announcements 21

Sep 13, 2018: Faron Pharmaceuticals: Interim results for the six months ended 30 June 2018 21

May 08, 2018: Faron Pharmaceuticals: Final Results for the year ended 31 December 2017 26

Sep 06, 2017: Faron Pharmaceuticals: Interim Results for the six months ended 30 June 2017 27

Corporate Communications 28

Dec 01, 2017: Faron Pharmaceuticals Oy: Appointment of Chief Commercial Officer 28

Appendix 29

Methodology 29

About GlobalData 29

Contact Us 29

Disclaimer 29


List Of Figure

List of Figures

Faron Pharmaceuticals Oy, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Faron Pharmaceuticals Oy, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Faron Pharmaceuticals Oy, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Faron Pharmaceuticals Oy, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Faron Pharmaceuticals Oy, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Faron Pharmaceuticals Oy, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Faron Pharmaceuticals Oy, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Faron Pharmaceuticals Oy, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

Faron Pharmaceuticals Oy, Medical Equipment, Key Facts, 2017 2

Faron Pharmaceuticals Oy, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Faron Pharmaceuticals Oy, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Faron Pharmaceuticals Oy, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Faron Pharmaceuticals Oy, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Faron Pharmaceuticals Oy, Deals By Market, 2012 to YTD 2018 8

Faron Pharmaceuticals Oy, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Faron Pharma Raises USD10 Million in Second Tranche of Private Placement of Shares 10

Faron Pharma Raises USD0.5 Million in Second Tranche of Rights Offering of Shares 12

Faron Pharma Raises USD13.3 Million in Private Placement of Shares 13

Faron Pharma Raises USD11.9 Million in Private Placement of Shares 14

Faron Pharma Raises USD1.3 Million in Rights Offering of Shares 15

Faron Pharma to Raise USD0.1 Million in Private Placement of Shares upon Exercise of Warrants 16

Faron Pharma Raises Funds in IPO 17

Faron Pharmaceuticals Oy, Key Competitors 18

Faron Pharmaceuticals Oy, Key Employees 19

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Faron Pharmaceuticals Oy, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.